Company Filing History:
1 out of 9 
1 out of 5 Years Active: 2020
Title: Peipei Cao: Innovator in Bispecific Antibody Development
Introduction
Peipei Cao is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. Her innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Peipei Cao holds a patent for a bispecific antibody that binds to human CD26 and human CD3. The patent describes a method for producing this bispecific antibody, which can be utilized in the preparation of drugs aimed at treating tumors with high cell expression of CD26. This antibody uniquely binds to both human CD26 and human CD3 simultaneously, showcasing its potential therapeutic applications.
Career Highlights
Throughout her career, Peipei Cao has worked with notable organizations such as Zonhon Biopharma Institute, Inc. and Gensun Institute of Biomedicine Co., Ltd. Her experience in these institutions has allowed her to advance her research and contribute to the field of antibody development.
Collaborations
Peipei Cao has collaborated with esteemed colleagues, including Yong Ma and Anliang Wang. These partnerships have fostered a collaborative environment that enhances innovation and research in biomedicine.
Conclusion
Peipei Cao's work in bispecific antibodies represents a significant advancement in cancer treatment. Her innovative approach and collaborations with leading professionals in the field highlight her commitment to improving therapeutic options for patients.